Mirae Asset Global Etfs Holdings Ltd. Biomarin Pharmaceutical Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 52,348 shares of BMRN stock, worth $3.47 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
52,348Holding current value
$3.47 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
620Shares Held
183MCall Options Held
1.41MPut Options Held
1.31M-
Black Rock Inc. New York, NY22.7MShares$1.51 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.26 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.25 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$925 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$643 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...